Launched in 2015, Verily is a subsidiary of Alphabet focused on life sciences and healthcare.

Verily partners with leading life sciences, medical device and government organizations, using hardware, software, scientific, and healthcare expertise to enable faster development, advances, and deployment at scale.

In May 2019, the company has announced partnership with Novartis, Otsuka Pharmaceutical, Pfizer and Sanofi in a project that aims to engage patients and clinicians in research and speed evidence generation.